Ieq Capital LLC Reduces Stake in Encompass Health Corporation $EHC

Key Points

• Ieq Capital LLC reduced its stake in Encompass Health Corporation by 43.9%, holding 24,873 shares worth approximately $2.52 million as of the latest SEC filing.
• Encompass Health reported quarterly earnings with an EPS of $1.40, exceeding the consensus estimate by $0.20, and generating revenue of $1.46 billion, up 12% from the previous year.
• The company increased its quarterly dividend from $0.17 to $0.19, with a payout ratio of 13.31%, representing an annualized yield of 0.6%.

Ieq Capital LLC reduced its stake in Encompass Health Corporation (NYSE:EHC - Free Report) by 43.9% during the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 24,873 shares of the company's stock after selling 19,483 shares during the period. Ieq Capital LLC's holdings in Encompass Health were worth $2,519,000 at the end of the most recent quarter.

Other large investors also recently added to or reduced their stakes in the company. Keeley Teton Advisors LLC raised its stake in shares of Encompass Health by 1.1% in the first quarter. Keeley Teton Advisors LLC now owns 23,449 shares of the company's stock valued at $2,375,000 after acquiring an additional 248 shares in the last quarter. Virtus Advisers LLC purchased a new stake in Encompass Health during the 1st quarter worth about $395,000. Synovus Financial Corp increased its holdings in Encompass Health by 10.2% during the 1st quarter. Synovus Financial Corp now owns 9,384 shares of the company's stock worth $950,000 after purchasing an additional 869 shares during the period. Campbell & CO Investment Adviser LLC purchased a new stake in shares of Encompass Health during the first quarter worth approximately $2,045,000. Finally, Oliver Luxxe Assets LLC raised its holdings in Encompass Health by 6.4% in the first quarter. Oliver Luxxe Assets LLC now owns 64,413 shares of the company's stock valued at $6,524,000 after acquiring an additional 3,860 shares in the last quarter. 97.25% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

Several equities analysts recently commented on EHC shares. KeyCorp increased their target price on Encompass Health from $122.00 to $135.00 and gave the company an "overweight" rating in a report on Tuesday, May 27th. UBS Group lifted their price target on Encompass Health from $130.00 to $140.00 and gave the stock a "buy" rating in a report on Wednesday, August 6th. Truist Financial lifted their price target on Encompass Health from $135.00 to $140.00 and gave the stock a "buy" rating in a report on Thursday, August 14th. Wall Street Zen downgraded Encompass Health from a "strong-buy" rating to a "buy" rating in a report on Friday, June 6th. Finally, Stephens upgraded shares of Encompass Health from an "overweight" rating to a "strong-buy" rating and set a $135.00 price target on the stock in a research note on Thursday, June 5th. One analyst has rated the stock with a Strong Buy rating and six have given a Buy rating to the company. Based on data from MarketBeat, the company presently has a consensus rating of "Buy" and an average price target of $134.00.

Encompass Health Stock Performance

Shares of Encompass Health stock traded up $0.59 during trading on Thursday, reaching $124.22. The company's stock had a trading volume of 227,975 shares, compared to its average volume of 809,244. The company has a 50-day moving average price of $116.80 and a two-hundred day moving average price of $111.54. The firm has a market cap of $12.51 billion, a PE ratio of 24.31, a P/E/G ratio of 2.13 and a beta of 0.92. Encompass Health Corporation has a fifty-two week low of $87.85 and a fifty-two week high of $124.68. The company has a current ratio of 1.06, a quick ratio of 1.06 and a debt-to-equity ratio of 0.76.

Encompass Health (NYSE:EHC - Get Free Report) last issued its quarterly earnings results on Monday, August 4th. The company reported $1.40 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.20 by $0.20. Encompass Health had a return on equity of 17.83% and a net margin of 9.22%.The firm had revenue of $1.46 billion for the quarter, compared to analysts' expectations of $1.43 billion. During the same quarter in the previous year, the firm posted $1.11 EPS. The firm's revenue for the quarter was up 12.0% on a year-over-year basis. Encompass Health has set its FY 2025 guidance at 5.120-5.340 EPS. On average, analysts forecast that Encompass Health Corporation will post 4.8 EPS for the current year.

Encompass Health Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Wednesday, October 15th. Stockholders of record on Wednesday, October 1st will be paid a dividend of $0.19 per share. This is a boost from Encompass Health's previous quarterly dividend of $0.17. The ex-dividend date of this dividend is Wednesday, October 1st. This represents a $0.76 dividend on an annualized basis and a dividend yield of 0.6%. Encompass Health's dividend payout ratio is currently 14.87%.

Insider Buying and Selling at Encompass Health

In other news, EVP Patrick William Tuer sold 1,020 shares of the company's stock in a transaction on Wednesday, August 27th. The shares were sold at an average price of $123.59, for a total transaction of $126,061.80. Following the transaction, the executive vice president directly owned 18,846 shares of the company's stock, valued at $2,329,177.14. This represents a 5.13% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. 2.00% of the stock is currently owned by company insiders.

Encompass Health Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.